Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
JAGX = Happy New Year to all my followers and not only ... I wanted to give you a small gift for the beginning of the year ... here the risk of return is very very favorable ... We have a very long-term bowl that in a short time has given strong signals awakening ... you see the volumes and more, it presents a very very promising conformation .. If we add that a...
This video analysis is for DebonairLizard who requested this for all you guys to benefit from. i show you a potential buy zone and targets that may be taking this asset higher. lets see if it plays out as we patiently wait for this asset's price to come down to more reasonable buy areas. thank you for your valuable time. Also for all you amazing people who are...
This was my first buy signal on Jaguar Health: The company signed an agreement for a non-dilutive royalty financing transaction. Jaguar will sell a royalty interest of future royalties of its Mytesi® (crofelemer) and lechlemer for an aggregate purchase...
Curious to see wether the current C&H pattern will play out.
Alerts et for break above $ 1.30 Opens up a move to much higher , use pivots as targets Previous targets hit , big winner for us
there look's to be some fuel left in this rally, above this level there is very little price resistance, so we aim for the 100ma as a possible target
JAGX just formed a smaller cup and handle and completed a measured move to the upside. On the larger time frame it appears to be curling the handle for another measured move to the upside bringing it to the gap fill in the 2.24 - $2.50 range
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the...
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the...
just one things they have planned for monday's conference can shoot this stock into the next galaxy.
Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required...
Jaguar Health Signs Second Agreement for $6 Million Non-dilutive Financing Transaction Involving the Sale of Royalty Rights Related to Future Mytesi (Crofelemer) and Lechlemer Revenue Stream Jaguar Health, Inc. has signed an agreement (the "Agreement") with a secured lender (the "Lender") for a non-dilutive royalty financing transaction, pursuant to which Jaguar...